Error: Could not add to watchlist. X

Ultragenyx Pharmaceutical Inc

+ Watchlist
RARE:US
NASDAQ GS
99.31
USD
2.36
2.43%
As of 11:03:35 ET on 10/26/2015.
Open
96.28
Day Range
93.33 - 99.41
Volume
131,450
Previous Close
96.95
52Wk Range
38.01 - 137.05
1 Yr Return
97.75%
Open
96.28
Day Range
93.33 - 99.41
Volume
131,450
Previous Close
96.95
52Wk Range
38.01 - 137.05
1 Yr Return
97.75%
YTD Return
126.32%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-2.48
Market Cap (b USD)
3.750
Shares Outstanding (m)
38.682
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.

Company News

Press Releases

There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Ultragenyx Pharmaceutical Inc. provides biotechnology services. The Company develops therapeutics and sialic acid for treating metabolic, body myopathy, glucuronidase, and rare genetic diseases. Ultragenyx Pharmaceutical conducts its business in the United States.
ADDRESS
60 Leveroni Court
Novato, CA 94949
United States
PHONE
1-415-483-8800
WEBSITE
www.ultragenyx.com

Executives

Board Members

  • Emil D Kakkis
    President/CEO/Founder
  • Thomas R Kassberg "Tom"
    Senior VP/ Chief Business Ofcr
  • Jayson Dallas
    Senior VP/Chief Commercial Ofcr
  • Dennis Huang
    Senior VP/Chief Technical Ops Ofcr
  • Sunil Agarwal
    Senior VP/Chief Medical Ofcr
Show More